Center For Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,082
Closed -$400K 149
2025
Q4
$400K Sell
16,082
-1,865
-10% -$47K 0.21% 97
2025
Q3
$457K Sell
17,947
-16,448
-48% -$406K 0.24% 84
2025
Q2
$909K Buy
34,395
+16,252
+90% +$379K 0.56% 42
2025
Q1
$460K Sell
18,143
-16,909
-48% -$442K 0.28% 77
2024
Q4
$930K Buy
35,052
+1,243
+4% +$33.7K 0.6% 39
2024
Q3
$978K Buy
33,809
+550
+2% +$16K 0.58% 42
2024
Q2
$931K Buy
33,259
+990
+3% +$27.3K 0.62% 38
2024
Q1
$895K Sell
32,269
-944
-3% -$26.2K 0.73% 30
2023
Q4
$956K Sell
33,213
-2,513
-7% -$76K 0.87% 27
2023
Q3
$1.19M Buy
35,726
+1,698
+5% +$60K 1.18% 21
2023
Q2
$1.25M Buy
34,028
+10,134
+42% +$394K 1.18% 20
2023
Q1
$975K Buy
23,894
+5,228
+28% +$226K 0.95% 22
2022
Q4
$956K Buy
18,666
+3,902
+26% +$187K 0.89% 28
2022
Q3
$646K Buy
14,764
+1,407
+11% +$68.4K 0.64% 37
2022
Q2
$700K Sell
13,357
-1,482
-10% -$75.5K 0.65% 36
2022
Q1
$768K Buy
14,839
+3,899
+36% +$202K 0.59% 36
2021
Q4
$646K Buy
10,940
+2,125
+24% +$105K 0.48% 45
2021
Q3
$379K Sell
8,815
-586
-6% -$26K 0.32% 57
2021
Q2
$368K Buy
9,401
+1,790
+24% +$69.6K 0.32% 58
2021
Q1
$276K Buy
7,611
+431
+6% +$15.3K 0.26% 67
2020
Q4
$264K Buy
+7,180
New +$263K 0.26% 66

Other funds holding PFE

Center For Asset Management's PFE Position: Q1 2026 in Review

Center For Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 16,082 shares — an estimated $400K sold.

Center For Asset Management first reported a position in PFE in Q4 2020 and held it in 21 quarters. The position peaked at $1.25M in Q2 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Center For Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Center For Asset Management sold 16,082 Pfizer shares in Q1 2026, an estimated $400K.
  • Center For Asset Management first reported a position in Pfizer in Q4 2020 and held it in 21 quarters.
  • Center For Asset Management's Pfizer position peaked at $1.25M in Q2 2023.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Center For Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.